JP2001523239A - 腸洗浄を促進するための5ht▲下3▼拮抗薬の使用 - Google Patents
腸洗浄を促進するための5ht▲下3▼拮抗薬の使用Info
- Publication number
- JP2001523239A JP2001523239A JP54502298A JP54502298A JP2001523239A JP 2001523239 A JP2001523239 A JP 2001523239A JP 54502298 A JP54502298 A JP 54502298A JP 54502298 A JP54502298 A JP 54502298A JP 2001523239 A JP2001523239 A JP 2001523239A
- Authority
- JP
- Japan
- Prior art keywords
- antagonists
- laxative
- laxatives
- antagonist
- combination
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.緩下剤と組み合せて腸洗浄を加速するための薬剤の製造のための5HT3 拮抗薬の使用。 2.緩下剤と組み合せて便秘を治療するための薬剤の製造のための5HT3拮 抗薬の使用。 3.5HT3拮抗薬がアザセトロン(Azasetron)、グラニセトロン (Granisetron)、オンダンセトロン(Ondansetron)、 トロピセトロン(Tropisetron)、DAT−582、ドラセトロン( Dolasetron)、イタセトロン(Itasetron)、N−3389 、パンコプリド(Pancopride)、ラモセトロン(Ramosetro n)、RG−12915、(R)−ザコプリド((R)−Zacopride) 、ルロセトロン(Lurosetron)、E−3620、GK−128、KB −6933、KF−20170、SL−90.0539および(−)−シス−4 −アミノ−5−クロロ−2,3−ジヒドロ−N−[1−[3−[(3,4−ジヒ ドロ−4−オキソ−2−ピリミジニル)アミノ]−プロピル]−3−メトキシ− 4−ピペリジニル]−2,2−ジメチル−7−ベンゾフランカルボキサミド並び にそれらの薬学的に許容されうる酸付加塩よりなる群から選ばれる請求の範囲第 1項〜第2項に記載の使用。 4.緩下剤が浸透剤である請求の範囲第1項〜第3項に記載の使用。 5.緩下剤がポリエチレングリコール(PEG)−電解質溶液である請求の範 囲第1項〜第3項に記載の使用。 6.緩下剤および5HT3拮抗薬が各々個別の経口剤形で投与される 請求の範囲第1項〜第5項のいずれか一項に記載の使用。 7.緩下剤および5HT3拮抗薬が一緒に組み合せ経口剤形で投与される請求 の範囲第1項〜第5項のいずれか一項に記載の使用。 8.便秘の治療における同時、個別または連続使用のためか或いは腸洗浄を加 速するための5HT3拮抗薬および浸透剤を含んでなる製品であって、但し該製 品はオピオイド拮抗薬を含有しない。 9.有効量の5HT3拮抗薬と組み合せて緩下剤を投与することによる哺乳類 の腸洗浄の加速方法。 10.有効量の5HT3拮抗薬と組み合せて緩下剤を投与することによる哺乳類 の便秘の冶療方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP97201149 | 1997-04-18 | ||
EP97201149.8 | 1997-04-18 | ||
PCT/EP1998/002356 WO1998047481A1 (en) | 1997-04-18 | 1998-04-14 | Use of 5ht3 antagonists for promoting intestinal lavage |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2001523239A true JP2001523239A (ja) | 2001-11-20 |
Family
ID=8228223
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP54502298A Ceased JP2001523239A (ja) | 1997-04-18 | 1998-04-14 | 腸洗浄を促進するための5ht▲下3▼拮抗薬の使用 |
Country Status (12)
Country | Link |
---|---|
US (2) | US6235745B1 (ja) |
EP (1) | EP0975327B1 (ja) |
JP (1) | JP2001523239A (ja) |
KR (1) | KR100529512B1 (ja) |
AT (1) | ATE243993T1 (ja) |
AU (1) | AU745361B2 (ja) |
CA (1) | CA2286076C (ja) |
DE (1) | DE69816060T2 (ja) |
DK (1) | DK0975327T3 (ja) |
ES (1) | ES2202855T3 (ja) |
PT (1) | PT975327E (ja) |
WO (1) | WO1998047481A1 (ja) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2010500368A (ja) * | 2006-08-07 | 2010-01-07 | アルバニー モルキュラー リサーチ,インコーポレイテッド | 5ht3モジュレーターとしての2−アミノベンゾオキサゾールカルボキサミド |
JP2016514102A (ja) * | 2013-02-25 | 2016-05-19 | シナジー ファーマシューティカルズ インコーポレイテッド | 結腸洗浄において用いるためのグアニル酸シクラーゼ受容体アゴニスト |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1090638A1 (en) * | 1999-10-08 | 2001-04-11 | Sanofi-Synthelabo | Use of (R)-zacopride or a salt thereof for the manufacture of a medicament for the treatment of sleep apnea |
US20040096423A1 (en) * | 2000-11-24 | 2004-05-20 | Megens Antonius Adrianus Hendrikus Petrus | Use of a triple combination comprising a 5ht3 antagonist, a 5ht4agonist and a laxative for promoting intestinal lavage |
PE20021019A1 (es) | 2001-04-19 | 2002-11-13 | Upjohn Co | Grupos azabiciclicos sustituidos |
US20040048874A1 (en) * | 2001-05-22 | 2004-03-11 | Bardsley Hazel Judith | New therapeutic use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-D]pyrimidine |
GB0216027D0 (en) * | 2002-07-10 | 2002-08-21 | Arachnova Therapeutics Ltd | New therapeutic use |
TWI332943B (en) * | 2001-07-10 | 2010-11-11 | Synta Pharmaceuticals Corp | Taxol enhancer compounds |
US6946149B2 (en) * | 2002-04-30 | 2005-09-20 | Braintree Laboratories, Inc. | Salt solution for colon cleansing |
JP2006503864A (ja) * | 2002-10-01 | 2006-02-02 | ジヨンソン・アンド・ジヨンソン・フアーマシユーチカル・リサーチ・アンド・デベロツプメント・インコーポレーテツド | タンパク質チロシンキナーゼ阻害剤としての4,6−ジアミノ置換−2−[オキシ又はアミノキシ]−[1,3,5]トリアジン |
US6996500B2 (en) * | 2002-10-30 | 2006-02-07 | Hewlett-Packard Development Company, L.P. | Method for communicating diagnostic data |
DE602004005814T2 (de) * | 2003-01-13 | 2008-01-10 | Dynogen Pharmaceuticals Inc., Waltham | Verfahren zur behandlung von übelkeit, erbrechen, würgereiz oder jede kombination daraus |
AU2004204825B2 (en) * | 2003-01-13 | 2007-07-19 | Dynogen Pharmaceuticals, Inc. | Method of treating functional bowel disorders |
EP1539181B1 (en) * | 2003-04-04 | 2007-06-27 | Dynogen Pharmaceuticals Inc. | Method of treating lower urinary tract disorders |
US7049319B2 (en) | 2003-09-23 | 2006-05-23 | Semaan Abboud | Colon cleansing composition and method |
EP1736156A4 (en) * | 2004-04-15 | 2010-06-16 | Eisai R&D Man Co Ltd | COMPOSITION CONTAINING 4-AMINO-5-CHLORO-N-¬ (1R, 3R, 5S) -8-METHYL-8-AZABICYCLO-3.2.1 OCT-3-YL-2-β-methyl-2-ynyloxy BENZAMIDE STABILIZED |
US20060293309A1 (en) * | 2005-03-28 | 2006-12-28 | Dynogen Pharmaceuticals, Inc. | Method of treating disorders and conditions using peripherally-restricted antagonists and inhibitors |
WO2007019888A2 (en) * | 2005-08-12 | 2007-02-22 | Ctg Pharma S.R.L. | Therapeutic compositions containing mesalamine and a co-agent for treating colon diseases |
EP1940375A1 (en) * | 2005-08-16 | 2008-07-09 | Synta Pharmaceuticals Corporation | Bis(thio-hydrazide amide) formulation |
CA2620333A1 (en) * | 2005-08-26 | 2007-03-01 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation |
US7553846B2 (en) | 2006-08-07 | 2009-06-30 | Albany Molecular Research, Inc. | 2-alkylbenzoxazole carboxamides as 5-HT3 modulators |
RS59667B1 (sr) | 2013-03-15 | 2020-01-31 | Braintree Laboratories Inc | Oralna farmaceutska kompozicija sulfatnih soli u obliku tableta dvostruke primene i postupci njihove upotrebe |
US10172833B2 (en) | 2015-08-11 | 2019-01-08 | Insys Development Company, Inc. | Sublingual ondansetron spray |
US10143656B1 (en) | 2017-08-04 | 2018-12-04 | Braintree Laboratories, Inc. | Solid oral sulfate salt formulations for cleaning a colon and methods of using same |
EP3858828A4 (en) * | 2018-09-28 | 2022-07-06 | Takeda Pharmaceutical Company Limited | HETEROCYCLIC COMPOUND |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB893267A (en) * | 1958-11-25 | 1962-04-04 | Sterling Drug Inc | Laxative enemas |
US5166145A (en) * | 1990-09-10 | 1992-11-24 | Alza Corporation | Antiemetic therapy |
TW294595B (ja) * | 1992-11-20 | 1997-01-01 | Janssen Pharmaceutica Nv | |
WO1996014071A1 (es) * | 1994-11-04 | 1996-05-17 | Legarda Ibanez Juan Jose | Combinacion de farmacos como medicamento destinado a supresion de dependencia de individuos a opiaceos |
US6103734A (en) | 1994-11-04 | 2000-08-15 | Legarda Ibanez; Juan Jose | Drug combination as a medicament to suppress the dependence of individuals to opiates |
US5576317A (en) * | 1994-12-09 | 1996-11-19 | Pfizer Inc. | NK-1 receptor antagonists and 5HT3 receptor antagonists for the treatment of emesis |
-
1998
- 1998-04-14 WO PCT/EP1998/002356 patent/WO1998047481A1/en active IP Right Grant
- 1998-04-14 AU AU75282/98A patent/AU745361B2/en not_active Ceased
- 1998-04-14 ES ES98922759T patent/ES2202855T3/es not_active Expired - Lifetime
- 1998-04-14 JP JP54502298A patent/JP2001523239A/ja not_active Ceased
- 1998-04-14 EP EP98922759A patent/EP0975327B1/en not_active Expired - Lifetime
- 1998-04-14 PT PT98922759T patent/PT975327E/pt unknown
- 1998-04-14 CA CA002286076A patent/CA2286076C/en not_active Expired - Lifetime
- 1998-04-14 US US09/403,248 patent/US6235745B1/en not_active Expired - Lifetime
- 1998-04-14 DK DK98922759T patent/DK0975327T3/da active
- 1998-04-14 DE DE69816060T patent/DE69816060T2/de not_active Expired - Lifetime
- 1998-04-14 KR KR10-1999-7007936A patent/KR100529512B1/ko not_active IP Right Cessation
- 1998-04-14 AT AT98922759T patent/ATE243993T1/de not_active IP Right Cessation
-
2001
- 2001-03-08 US US09/801,978 patent/US6555546B2/en not_active Expired - Lifetime
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2010500368A (ja) * | 2006-08-07 | 2010-01-07 | アルバニー モルキュラー リサーチ,インコーポレイテッド | 5ht3モジュレーターとしての2−アミノベンゾオキサゾールカルボキサミド |
JP2016514102A (ja) * | 2013-02-25 | 2016-05-19 | シナジー ファーマシューティカルズ インコーポレイテッド | 結腸洗浄において用いるためのグアニル酸シクラーゼ受容体アゴニスト |
Also Published As
Publication number | Publication date |
---|---|
AU745361B2 (en) | 2002-03-21 |
US6235745B1 (en) | 2001-05-22 |
CA2286076C (en) | 2006-12-12 |
ES2202855T3 (es) | 2004-04-01 |
KR20000075858A (ko) | 2000-12-26 |
DE69816060T2 (de) | 2004-04-22 |
PT975327E (pt) | 2003-11-28 |
EP0975327B1 (en) | 2003-07-02 |
DE69816060D1 (de) | 2003-08-07 |
ATE243993T1 (de) | 2003-07-15 |
US20010020025A1 (en) | 2001-09-06 |
US6555546B2 (en) | 2003-04-29 |
EP0975327A1 (en) | 2000-02-02 |
WO1998047481A1 (en) | 1998-10-29 |
AU7528298A (en) | 1998-11-13 |
DK0975327T3 (da) | 2003-10-20 |
CA2286076A1 (en) | 1998-10-29 |
KR100529512B1 (ko) | 2005-11-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2001523239A (ja) | 腸洗浄を促進するための5ht▲下3▼拮抗薬の使用 | |
AU2004292428B2 (en) | Colonic purgative composition with soluble binding agent | |
RU2602739C2 (ru) | Производное пиразола и его применение в медицинских целях | |
US6083933A (en) | Treatment of cystitis-like symptoms with chondroitin sulfate following administration of a challenge solution | |
AU708778B2 (en) | Pharmaceutical compositions comprising an opiate antagonist and calcium salts, their use for the treatment of endorphin-mediated pathologies | |
US20040092511A1 (en) | Pharmaceutical combinations and their use in treating gastrointestinal and abdominal viscera disorders | |
US20050192270A1 (en) | Methods of decreasing intestinal motility | |
KR20010015707A (ko) | 의약 | |
US20160279166A1 (en) | Treating agent and treating method for the examination or operation of the large intestine | |
JP2002511074A (ja) | 駆虫性組成物 | |
JP2004513969A (ja) | 腸洗浄を促進するための5ht3アンタゴニスト、5ht4アゴニスト及び緩下薬を含んでなる三種類の組み合わせの使用 | |
US4904673A (en) | Agent for treating bradycardia and bradyarrhythmia | |
Hall | Non-specific drug therapy | |
MXPA00003375A (en) | Medicaments |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20050225 |
|
RD02 | Notification of acceptance of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7422 Effective date: 20080205 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20080520 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20080820 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20080929 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20081119 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20090414 |
|
A313 | Final decision of rejection without a dissenting response from the applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A313 Effective date: 20090803 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20090915 |